Page 151 - Hematology_ Basic Principles and Practice ( PDFDrive )

110.e12 Part II Cellular Basis of Hematology

Proc Natl Acad Sci USA 103:13783–13788, 2006. doi: 10.1073/ 519. Whang J, Frei E, 3rd, Tjio JH, et al: The Distribution of the Philadel-
pnas.0604006103. phia Chromosome in Patients with Chronic Myelogenous Leukemia.
497. Chung YJ, et al: Unique effects of Stat3 on the early phase of hema- Blood 22:664–673, 1963.
topoietic stem cell regeneration. Blood 108:1208–1215, 2006. doi: 520. Martin PJ, et al: Involvement of the B-lymphoid system in chronic
10.1182/blood-2006-01-010199. myelogenous leukaemia. Nature 287:49–50, 1980.
498. Avecilla ST, et al: Chemokine-mediated interaction of hematopoietic 521. Fialkow PJ, Gartler SM, Yoshida A: Clonal origin of chronic myelocytic
progenitors with the bone marrow vascular niche is required for leukemia in man. Proc Natl Acad Sci USA 58:1468–1471, 1967.
thrombopoiesis. Nat Med 10:64–71, 2004. doi: 10.1038/nm973. 522. Levan A, Norden A, Nichols WW: A Case of Chronic Myeloid Leuke-
499. Hooper AT, et al: Engraftment and reconstitution of hematopoi- mia with 2 Leukemic Stemlines in Blood. Hereditas 49:433–&, 1963.
esis is dependent on VEGFR2-mediated regeneration of sinusoidal 523. Jamieson CH, et al: Granulocyte-macrophage progenitors as candidate
endothelial cells. Cell Stem Cell 4:263–274, 2009. doi: 10.1016/j. leukemic stem cells in blast-crisis CML. N Engl J Med 351:657–667,
stem.2009.01.006. 2004. doi: 10.1056/NEJMoa040258.
500. Kopp HG, et al: Tie2 activation contributes to hemangiogenic 524. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a
regeneration after myelosuppression. Blood 106:505–513, 2005. doi: hierarchy that originates from a primitive hematopoietic cell. Nat Med
10.1182/blood-2004-11-4269. 3:730–737, 1997.
501. Salter AB, et al: Endothelial progenitor cell infusion induces hemato- 525. Huntly BJ, Gilliland DG: Leukaemia stem cells and the evolution
poietic stem cell reconstitution in vivo. Blood 113:2104–2107, 2009. of cancer-stem-cell research. Nat Rev Cancer 5:311–321, 2005. doi:
doi: 10.1182/blood-2008-06-162941. 10.1038/nrc1592.
502. Chute JP, et al: Transplantation of vascular endothelial cells mediates 526. Ding L, et al: Clonal evolution in relapsed acute myeloid leukaemia
the hematopoietic recovery and survival of lethally irradiated mice. revealed by whole-genome sequencing. Nature 481:506–510, 2012.
Blood 109:2365–2372, 2007. doi: 10.1182/blood-2006-05-022640. doi: 10.1038/nature10738.
503. Doan PL, et al: Epidermal growth factor regulates hematopoietic 527. Ley TJ, et al: DNA sequencing of a cytogenetically normal acute
regeneration after radiation injury. Nat Med 19:295–304, 2013. doi: myeloid leukaemia genome. Nature 456:66–72, 2008. doi: 10.1038/
10.1038/nm.3070. nature07485.
504. Poulos MG, et al: Endothelial Jagged-1 is necessary for homeostatic 528. Mardis ER, et al: Recurring mutations found by sequencing an acute
and regenerative hematopoiesis. Cell Rep 4:1022–1034, 2013. doi: myeloid leukemia genome. N Engl J Med 361:1058–1066, 2009. doi:
10.1016/j.celrep.2013.07.048. 10.1056/NEJMoa0903840.
505. Geiger H, et al: Pharmacological targeting of the thrombomodulin- 529. Yan XJ, et al: Exome sequencing identifies somatic mutations of DNA
activated protein C pathway mitigates radiation toxicity. Nat Med methyltransferase gene DNMT3A in acute monocytic leukemia. Nat
18:1123–1129, 2012. doi: 10.1038/nm.2813. Genet 43:309–315, 2011. doi: 10.1038/ng.788.
506. Guinan EC, et al: Bactericidal/permeability-increasing protein 530. Kronke J, et al: Clonal evolution in relapsed NPM1-mutated
(rBPI21) and fluoroquinolone mitigate radiation-induced bone marrow acute myeloid leukemia. Blood 122:100–108, 2013. doi: 10.1182/
aplasia and death. Sci Transl Med 3:110ra118, 2011. doi: 10.1126/ blood-2013-01-479188.
scitranslmed.3003126. 531. Genovese G, et al: Clonal hematopoiesis and blood-cancer risk inferred
507. Kim JH, et al: NRF2-mediated Notch pathway activation enhances from blood DNA sequence. N Engl J Med 371:2477–2487, 2014. doi:
hematopoietic reconstitution following myelosuppressive radiation. J 10.1056/NEJMoa1409405.
Clin Invest 124:730–741, 2014. doi: 10.1172/JCI70812. 532. Jaiswal S, et al: Age-related clonal hematopoiesis associated with
508. Himburg HA, et al: Pleiotrophin mediates hematopoietic regenera- adverse outcomes. N Engl J Med 371:2488–2498, 2014. doi: 10.1056/
tion via activation of RAS. J Clin Invest 124:4753–4758, 2014. doi: NEJMoa1408617.
10.1172/JCI76838. 533. Ferrando AA, et al: Gene expression signatures define novel oncogenic
509. Zhou BO, Ding L, Morrison SJ: Hematopoietic stem and progenitor pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1:75–87,
cells regulate the regeneration of their niche by secreting Angiopoietin-1. 2002.
Elife 4:e05521, 2015. doi: 10.7554/eLife.05521. 534. Chambers J, Rabbitts TH: LMO2 at 25 years: a paradigm of chromo-
510. Rossi DJ, et al: Cell intrinsic alterations underlie hematopoietic stem somal translocation proteins. Open Biol 5:150062, 2015. doi: 10.1098/
cell aging. Proc Natl Acad Sci USA 102:9194–9199, 2005. doi: 10.1073/ rsob.150062.
pnas.0503280102. 535. Collin M, Dickinson R, Bigley V: Haematopoietic and immune defects
511. Woolthuis CM, et al: Aging impairs long-term hematopoietic regen- associated with GATA2 mutation. Brit J Haematol 169:173–187, 2015.
eration after autologous stem cell transplantation. Biol Blood Marrow doi: 10.1111/bjh.13317.
Transplant 20:865–871, 2014. doi: 10.1016/j.bbmt.2014.03.001. 536. Imperato MR, Cauchy P, Obier N, et al: The RUNX1-PU.1 axis in
512. Rossi DJ, et al: Deficiencies in DNA damage repair limit the function the control of hematopoiesis. Int J Hematol 101:319–329, 2015. doi:
of haematopoietic stem cells with age. Nature 447:725–729, 2007. doi: 10.1007/s12185-015-1762-8.
10.1038/nature05862. 537. de Bruijn MF, Speck NA: Core-binding factors in hematopoiesis and
513. Flach J, et al: Replication stress is a potent driver of functional decline immune function. Oncogene 23:4238–4248, 2004. doi: 10.1038/
in ageing haematopoietic stem cells. Nature 512:198–202, 2014. doi: sj.onc.1207763.
10.1038/nature13619. 538. Ustun C, Marcucci G: Emerging diagnostic and therapeutic approaches
514. Cheng CW, et al: Prolonged fasting reduces IGF-1/PKA to promote in core binding factor acute myeloid leukaemia. Curr Opin Hematol
hematopoietic-stem-cell-based regeneration and reverse immuno- 22:85–91, 2015. doi: 10.1097/MOH.0000000000000124.
suppression. Cell Stem Cell 14:810–823, 2014. doi: 10.1016/j. 539. Tijchon E, Havinga J, van Leeuwen FN, et al: B-lineage transcription
stem.2014.04.014. factors and cooperating gene lesions required for leukemia develop-
515. O’Connor ML, et al: Cancer stem cells: a contentious hypothesis now ment. Leukemia 27:541–552, 2013. doi: 10.1038/leu.2012.293.
moving forward. Cancer Lett 344:180–187, 2014. doi: 10.1016/j. 540. Van Vlierberghe P, et al: ETV6 mutations in early immature human
canlet.2013.11.012. T cell leukemias. J Exp Med 208:2571–2579, 2011. doi: 10.1084/
516. Nguyen LV, Vanner R, Dirks P, et al: Cancer stem cells: an evolving jem.20112239.
concept. Nat Rev Cancer 12:133–143, 2012. doi: 10.1038/nrc3184. 541. Greig KT, Carotta S, Nutt SL: Critical roles for c-Myb in hematopoietic
517. Lapidot T, et al: A cell initiating human acute myeloid leukaemia after progenitor cells. Sem Immunol 20:247–256, 2008. doi: 10.1016/j.
transplantation into SCID mice. Nature 367:645–648, 1994. doi: smim.2008.05.003.
10.1038/367645a0. 542. Lieu YK, Reddy EP: Conditional c-myb knockout in adult hema-
518. Tough IM, Jacobs PA, Court Brown WM, et al: Cytogenetic studies topoietic stem cells leads to loss of self-renewal due to impaired
on bone-marrow in chronic myeloid leukaemia. Lancet 1:844–846, proliferation and accelerated differentiation. Proc Natl Acad Sci USA
1963. 106:21689–21694, 2009. doi: 10.1073/pnas.0907623106.